Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ.
about
The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activityA novel model for IFN-γ-mediated autoinflammatory syndromes.Regulation of stress-induced hematopoiesisAugmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonistsInterferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.Dendritic cell-based immunotherapy for myeloid leukemias.IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity.Regulation of hematopoietic and leukemic stem cells by the immune system.Calcitriol-mediated reduction in IFN-γ output in T cell large granular lymphocytic leukemia requires vitamin D receptor upregulation.Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling.A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells.The Regulatory Role of IFN-γ on the Proliferation and Differentiation of Hematopoietic Stem and Progenitor Cells.Chronic exposure to IFNα drives medullar lymphopoiesis towards T-cell differentiation in mice.CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemiaBlocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cellsInterferons in hematopoiesis and leukemia.The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion.Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.Targeting Leukemia Stem Cells in the Bone Marrow Niche.BCR-ABL-specific CD4+ T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cells.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.Interplay between inflammatory tumor microenvironment and cancer stem cells.
P2860
Q26851545-A72D0016-7E1B-4BBD-B223-888FF562D7D5Q35110844-1285BC27-D40D-45CF-8B52-0F34F4EE6384Q36069153-8E0FC07A-13DF-4D68-8BAB-6593C0A87CD5Q36546862-F8EB6BA0-9BF7-48E6-A609-E44BAC06888CQ36597361-3B81E012-B8F8-4F2B-B0BA-0177BA0F46CBQ37420778-18795D61-755A-4CE9-8070-195D281B7B54Q37676297-D09FD840-0F57-44C7-908E-6D8D2D4AEDF6Q38108353-0D96B8E9-66ED-44F2-824F-AA42A08B958EQ38225994-C24CE32E-894E-426D-A207-63C8BD86959EQ38696547-6BDB0F16-B80A-499D-B7D0-779A24401FA7Q38848102-2FFA0B67-6D6A-41C6-AC33-17BCC6122F0BQ39017947-4F1206E2-FADA-4DDC-A666-38E1FFAD2010Q40075042-B0103528-B828-4457-A4C6-9C3631FCB915Q40972881-73A8B8E6-4B1F-4A78-821B-7892FC0189D7Q42323497-181EE42C-F80A-42D1-89C7-4C8D56326337Q42428547-942EC9C1-26F6-4941-878E-747CB69F2695Q43084694-1073BF05-D185-433C-8025-50800E95E23BQ48337458-64D9DB92-D614-43D5-82F4-061C849D830EQ51075769-C57063BD-7FA5-4F59-8FEF-B502E0988145Q52375473-6B883DEC-F2FD-4A10-9EA7-0D3C3A3CF3CBQ54194418-C822B1E5-C29D-433C-94C6-27DD02A07C70Q55354182-40582979-0173-44A9-BD1F-E4F040395692Q55375210-68E30ABB-EF41-4626-B0D1-8BB5480CCE53
P2860
Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cytotoxic T cells induce proli ...... lls by secreting interferon-γ.
@ast
Cytotoxic T cells induce proli ...... lls by secreting interferon-γ.
@en
type
label
Cytotoxic T cells induce proli ...... lls by secreting interferon-γ.
@ast
Cytotoxic T cells induce proli ...... lls by secreting interferon-γ.
@en
prefLabel
Cytotoxic T cells induce proli ...... lls by secreting interferon-γ.
@ast
Cytotoxic T cells induce proli ...... lls by secreting interferon-γ.
@en
P2860
P50
P921
P356
P1476
Cytotoxic T cells induce proli ...... lls by secreting interferon-γ.
@en
P2093
Adrian F Ochsenbein
P2860
P304
P356
10.1084/JEM.20121229
P407
P577
2013-02-11T00:00:00Z